Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish

Hematopoiesis, the process of blood cell formation, requires precise regulation for proper development and function; dysregulation can lead to severe hematological disorders. Retinoic acid (RA) is a crucial, concentration-dependent regulator of both embryonic and adult hematopoiesis. Despite its known importance, the specific molecular mechanisms that fine-tune RA signaling within hematopoietic pathways remain largely undefined, representing a critical gap in understanding and therapeutic targeting.

Researchers utilized a zebrafish model to investigate regulators of hematopoietic homeostasis. They generated angptl5Δ10/Δ10 mutants to assess the impact of Angptl5 loss-of-function. The study focused on observing changes in myeloid and erythroid progenitor populations within the anterior lateral plate mesoderm (ALPM) and posterior lateral plate mesoderm (PLPM). Subsequent molecular analyses were performed to confirm impaired RA signaling in the mutants. A key intervention involved exogenous RA supplementation to determine if the observed hematopoietic defects could be rescued, thereby linking Angptl5's role directly to RA pathway modulation.

Loss of Angptl5 function in angptl5Δ10/Δ10 zebrafish mutants resulted in significant disruptions to primitive hematopoiesis. Specifically, the researchers observed myeloid hyperplasia in the ALPM and an anterior expansion of erythroid progenitors in the PLPM. These phenotypic changes were consistent with attenuated retinoic acid (RA) signaling. Molecular analyses confirmed that angptl5Δ10/Δ10 mutants exhibited impaired RA signaling.

Critically, exogenous RA supplementation fully rescued these hematopoietic defects, directly implicating RA pathway modulation in Angptl5's function. Mechanistically, Angptl5 was found to transcriptionally activate retinol dehydrogenase dhrs9 through its interaction with Integrin α6lβ5. This activation of dhrs9 likely enhances RA synthesis, thereby restricting primitive hematopoiesis. The study established Angptl5 as an essential regulator of embryonic hematopoiesis and elucidated a novel mechanism controlling hematopoietic homeostasis.